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Neurodegenerationagy) is a catabolic process responsible for the degradation of long-lived proteins,
molecules and organelles. Cellular stressors such as food limitation, space restriction, oxidative stress,
temperature shifts, and accumulation of protein aggregates induce autophagy. Cellular material to be
degraded is engulfed in autophagosomes, which fuse with the lysosome where material is degraded. Cellular
components can then be recycled. Autophagy has been assigned pro-survival and pro-death functions. Here,
we reviewed the roles of autophagy in cell growth and death, in ageing and longevity, as well as in
neurodegeneration in the nematode Caenorhabditis elegans.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionCaenorhabditis elegans is a soil nematode, which offers particular
advantages for the study of autophagic mechanisms at the whole
organism level: it is a hermaphrodite species, which is easily culti-
vated and maintained in the lab (males are also generated at low
frequency and can be used in genetic crosses [1]); it is transparent,
which permits microscopic visualization of speciﬁc cells and sub-
cellular structures; it has a short life cycle of 2.5 days at 25 °C (Fig. 1)
and produces a large number of progeny (between 200 and 300
offspring). Importantly, the lineage of the 959 cells in the adult is fully
described and invariable among animals [2,3]. This unique feature of
C. elegans greatly facilitates studies of development and cell death
[4–6]. In addition, detailed anatomical information is available for the
entire animal and the complete nervous system wiring diagram is
fully known [7,8]. Finally the availability of a completely sequencedtrophic lateral sclerosis; Atg,
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ll rights reserved.genome [9,10] coupled with efﬁcient forward and reverse genetics
methodologies, such as random mutagenesis, transgenesis and RNA
interference (RNAi), greatly facilitates the molecular characterization
of genes and biochemical pathways [11–13]. These exceptional
characteristics of the nematode model have allowed the detailed
dissection of autophagic mechanisms in the context of animal deve-
lopment, nervous system function and ageing.
Three major pathways are involved in the degradation of cellular
material, the ubiquitin–proteosome system, chaperone-mediated
degradation and autophagy [14,15]. The ﬁrst pathway is responsible
for the degradation of short-lived proteins. The chaperone-
mediated pathway directs for degradation cytosolic proteins that
carry a particular pentapeptide consensus motif. Autophagy is a
catabolic process responsible for the degradation of long-lived
proteins, molecules and organelles. Cellular stressors such as
nutrient limitation, amino acid deﬁciency, space restriction,
hypoxia, oxidative stress, temperature shifts, and accumulation of
protein aggregates and damaged organelles induce autophagy.
Autophagic degradation occurs through three pathways, micro-
autophagy, macroautophagy (or autophagy herein), and chaperone-
mediated autophagy. In chaperone-mediated autophagy, a protein
destined to degradation is tagged by a chaperone, such as hsc 70. The
complex then binds to a receptor on the lysosomal membrane, and
the tagged protein enters the lumen where it is degraded (Fig. 2)
[16]. During microautophagy, cellular material is directly engulfed
into the lysosome by invagination of its membrane, followed by
ﬁssion of the formed vesicle into the lysosome lumen [14,15,17].
Microautophagy and macroautophagy differ in the manner by
Fig. 1. The C. elegans lifecycle. Adult worms lay eggs that hatch into larvae, which undergo four larval stages of development (L1–L4) before maturing into an adult. Upon adverse
environmental conditions, such as limited food supply, L1 larvae cease their growth, while L2 larvae develop into dauer larvae, an alternative developmental formwhich can survive
harsh conditions. When dauer larvae encounter favourable environment, they re-enter the lifecycle at the L4 stage to resume development.
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macroautophagy, the cellular material to be degraded is engulfed in
double-membrane vesicles (300–900 nm in diameter), termed
autophagosomes. These vesicles are targeted to the lysosome via a
dynein-related pathway, where they bind and fuse with the
lysosome membrane. The autophagic bodies that contain the
material to be degraded are delivered into the lysosomal lumen,
where acidic hydrolases degrade the cargo and ﬁnally, material is
recycled by being re-exported back to the cytoplasm [14,18].
Autophagy is a ubiquitous conserved process implicated in normal
development, ageing, disease and cell death. Autophagy research has
been greatly facilitated by the discovery and characterization of auto-
phagy genes in yeast and subsequently in other organisms, such as
Drosophila, mice and C. elegans (Table 1) [14,18–20]. These studies
have also elucidated the involvement of autophagy in human health
and disease. Here, we review current research on the role of
autophagic pathways in C. elegans physiology and pathophysiology,
and also discuss the implications of these ﬁndings for similar studies
in other organisms.
2. Cell growth
Autophagy is required for normal cell size and thus body size in the
worms [21]. Two autophagy genes, unc-51 (the yeast orthologue of atg1,
encoding a serine–threonine kinase) and bec-1 (the yeast orthologue of
atg6, and thehumanorthologueof beclin 1)havebeen implicated in this
process. unc-51 mutant worms show defects in autophagy, and unc-51
loss-of-function mutations result in worms with signiﬁcantly shorter
mean body size. Interestingly, wild type and small mutant worms had
the same number of cells. Loss-of-function bec-1 mutations arrest
development at different stages. The insulin/insulin-like growth factor 1
(IGF-1) and the transforming growth factor beta (TGF-β) signalling
pathways have also been shown to affect cell size and thus body length
[21]. Animals with defective insulin/IGF-1 or TGF-β signalling have long
body size. Interestingly, knock down of unc-51 or bec-1 in these animals
results in either small or normal-sized worms. This epistatic effect
indicates that these two pathways exert their effects on body size via
autophagic mechanisms.Nematodes with feeding defects are smaller in size, have smaller
cells and their fat deposits are depleted. These characteristics are due
to activation of autophagy [22]. For example, eat-1, eat-2 and eat-3, or
pha-2 and pha-3 feeding mutants, which have reduced pharyngeal
pumping rates, or abnormal pharyngeal anatomy, are shorter and
thinner than wild type worms. Expression of lgg-1, a homologue to
yeast atg8 and mammalian MAP-LC3 [18], is increased in hypodermal
seam cells of L3 eat-3, pha-2 and pha-3worms, indicating induction of
autophagy.
3. Cell survival
Autophagy is paramount for survival of mammals at birth, when
the nutrient supply provided by the placenta is interrupted. At that
time, autophagy is up-regulated providing the nutrients necessary to
maintain cellular metabolism essential for survival by recycling
cytoplasmic components. [19]. Upon food limitation, overcrowding,
and temperature elevation C. elegans enters an alternative develop-
mental program, the dauer larval stage. During this transition, auto-
phagy is up-regulated to facilitate nutrient recycling [23]. Nutrient
deprivation also induces L1 diapause [23]. Starved L1 larvae also
depend on autophagy to provide the energy requirements for survival.
In C. elegans, pcm-1 mutations inhibit autophagy during dauer entry
and decrease the survival of L1 arrested larvae [24]. pcm-1 encodes a
methyltransferase that repairs the formation of L-isopartyl residues
on proteins, a common form of age-related protein damage. pcm-1
mutants show defects in dauer formation and their lifespan is
reduced.
Monitoring of autophagy in pcm-1 mutants by means of LGG-1/
Atg8/LC3 sub-cellular localization, which associates with pre-
autophagosomes and autophagosomes, shows that the function of
PCM-1 is required for proper induction of autophagy in dauer larvae
[23]. Under non-inducing conditions for autophagy, the LGG-1 protein
is localized diffusely in the cytoplasm of multiple tissues in C. elegans.
During dauer formation and in long-lived animals LGG-1 localization
in hypodermal seam cells shows a characteristic punctate staining that
is attributed to an increase in the number of pre-autophagosomes and
autophagosomes. However, the number of LGG-1-labelled puncta is
Fig. 2. Schematic diagram of the three types of autophagy in eukaryotes. In macroautophagy (or autophagy) regions of the cytoplasm containing molecules and organelles are
engulfed into autophagosomes and are subsequently delivered to the lysosome for degradation. In microautophagy, molecules for degradation are directly engulfed by the lysosome
membrane. In chaperone-mediated autophagy, chaperone proteins deliver material for degradation to the lysosome.
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the autophagic process is impaired [25].
4. Development
Autophagy is also involved in cellular remodelling during deve-
lopment. Speciﬁcally in the nervous system, there is evidence that it is
involved in synapse formation and remodelling. Upon de-innervation of
both cholinergic and GABAergic presynaptic inputs to worm body-wall
muscles, GABA, but not acetylcholine, receptors are internalized and
transported to autophagosomes for degradation [26]. Such directed
modiﬁcation greatly inﬂuences the balance between excitation and
inhibition. The involvement of autophagy in this selective process was
veriﬁed by testing for autophagosome formation in unc-51mutants. unc-
51 is required for axonal outgrowth along the antero-posterior axis. An
increased number of organelles containing tagged GABAA receptors in
non-innerved muscle cells were observed. Receptor internalization and
degradation is associated with autophagy since receptors co-localized
both with LGG-1 and BEC-1 in autophagosomes of non-innervated
muscles. Trafﬁcking of receptors to autophagosomes is most likely
occurring via the endocytic pathway since blocking endocytosis
prevented receptors from aggregating in autophagosomes [27].The presynaptic terminal is playing a critical role in keeping GABA
receptors inserted in the membrane as opposed to accumulating in
autophagosomes [27]. Indeed, the localization of GABAA receptors in
autophagosomes is increased in unc-3mutants that display defects in
nerve-muscle contacts. unc-3 is involved in axonal outgrowth ofmotor
neurons [28]. Importantly, non-innervated muscles were otherwise
healthy, as they did not show any signs of degeneration [27].
5. Ageing
Reducing calorie intake has been shown to extend lifespan in mice,
Drosophila and C. elegans [29–33]. Reduced insulin/IGF-1 signalling
also promotes longevity. [34]. In addition, mitochondrial activity has
been implicated in ageing [35]. Worms with mutations in the dauer
formation (daf) pathway, such as daf-2, live longer [36,37]. daf-2
encodes the C. elegans orthologue of the insulin/IGF-1 receptor
tyrosine kinase. DAF-2, through a phosphorylation cascade, which
involves the kinases AGE-1, AKT-1, AKT-2 and SKG-1, triggers
phosphorylation of the FOXO transcription factor DAF-16, blocking its
translocation to the nucleus and transcription of target genes [38,39].
The target of rapamycin (TOR) kinase (encoded by let-363 in C.
elegans; [5,20]) inhibits autophagy in the presence of sufﬁcient nu-
Table 1
Autophagy-related genes in Caenorhabditis elegans.
Autophagy-related genes Autophagy-related function C. elegans
homologueYeast gene Mammalian gene
Regulation of autophagy induction
TOR1/TOR2 Hs FRAP1 Rapamycin-sensitive Ser/Thr protein kinase let-363
ATG1 Hs ULK2/Mm Unc51.2 Ser/Thr protein kinase unc-51
Autophagosome nucleation
ATG6 Mm beclin 1 Component of class III PI3-kinase complex bec-1
VPS34 Hs PI3-kinase, class III Class III PI3-kinase vps-34
Autophagosome expansion and completion
ATG3 Hs ATG3/Mm Apg3 E2-like enzyme; conjugates Atg8 to PE Y55F3AM.4
ATG4 Hs ATG4/Mm autophagin 1 Cys protease; leaves C-terminal extension of PE from Atg8 Y87G2A.3
ATG5 Hs ATG5/Autophagy 5-like Conjugated to Atg12 through internal lysine atgr-5
ATG7 Hs ATG7/Mm APG7 E1-like enzyme; activates Atg8 and Atg12 atgr-7
ATG8 Hs GABARAP/Mm GABARAP-like 1 Ubiquitin-like protein conjugated to PE lgg-1
ATG10 Hs/Mm ATG10 E2-like enzyme; conjugates Atg12 to Atg5 D2085.2
ATG12 Hs APG12-like Ubiquitin-like protein conjugated to Atg5 lgg-3
ATG16 Hs APG16-like isoform 2 Component of Atg12-Atg5 complex K06A1.5
Retrieval of autophagic proteins
ATG9 Hs/Mm APG9-like 1 Integral membrane protein atgr-9
ATG18 Sc ATG18// Hs AAQ96867 Localization of Atg2 atgr-18
Genes are listed according to their function in each autophagic step.
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amino acid availability [40]. By contrast, under food deprivation TOR
is inhibited and autophagy is activated [40]. The insulin/IGF-1
pathway activates TOR and both pathways cooperate to ensure the
sufﬁcient presence of nutrients in cells, regulate cell growth and
inﬂuence natural lifespan [41,42].
Downregulation of the autophagy gene bec-1 reduces the longevity
of daf-2(e1370) mutant worms as compared to control animals
indicating that autophagy is required for lifespan extension by low
insulin/IGF-1 signalling [25]. In addition, knock down of atg-7 and atg-
12, which are orthologues of the yeast autophagy genes atg7 and atg12
respectively, diminishes lifespan extension induced bydaf-2mutations
and shortens the lifespan of otherwisewild typeworms [37]. Similarly,
inhibition of autophagy reverses the beneﬁcial effects of dietary
restriction on longevity of eat-2(ad1116) feeding defective mutants
[43]. This effect requires the PHA-4/FOXA transcription factor, which is
also shown to play a role in longevity, similar to DAF-16/FOXO [43,44].
Signalling through the insulin/IGF-1 pathway also directly regulates
SKN-1, a transcription factor which is involved in the response to
oxidative stress through the p38 MAPK pathway and also modulates
ageing. skn-1 mutations counteract lifespan extension conferred by
daf-2mutations as well as by downregulation of akt-1 and akt-2 [45].
An additional longevity determinant in C. elegans is the tumour
suppressor protein p53 [46]. Besides regulating DNA damage res-
ponses, senescence and apoptosis, p53 also plays a major role in the
control of autophagy [47,48]. Depletion of p53 induces autophagy in
human, mouse and nematode cells. Studies in C. elegans suggest that
the life span-extending effect of mutations in the cep-1 gene, encoding
the functional homologue of p53, is mediated by autophagy, which
promotes longevity in cep-1 mutant worms [49].
6. Cell death
Autophagic cell death or type II cell death, together with apoptosis
and necrosis, comprise the three main types of cell death originally
identiﬁed. Autophagic cell death is characterized by dramatic increase
in the number of autophagic vacuoles in the cytoplasm [50]. It is
uncertainwhether these accumulated vacuoles reﬂect a cell death or a
pro-survival mechanism [51]. Genetic studies in the nematode have
shown that excessive activation of autophagy has adverse effects for
survival [52]. These studies revealed that bec-1 is required for survival
upon starvation in the worm and that this effect is mediated bymuscurinic acetylcholine signalling, since over activation of choliner-
gic signalling induced excessive autophagy, whereas blocking it
decreased autophagy during starvation [53]. These ﬁndings suggest
that, at least in speciﬁc tissues of C. elegans (in this case pharyngeal
muscles), autophagy is promoting survival when induced at physio-
logic levels, while it may contribute to cell death when induced
excessively.
Three autophagy genes, unc-51, bec-1 and lgg-1, have been directly
implicated in mediating neural necrosis due to plasma membrane ion
channel hyperactivity, since inactivation of these genes suppressed
necrotic cell death [54]. The anti-apoptotic proteins Bcl-2 and Bcl-XL
interact with Beclin1 via their BH3 domain to inhibit autophagy.
Pharmacological interference with this interaction by mimetics that
bind BH3 receptors, as well as by overexpression of Bad, a BH3-only
protein, induces autophagy [55,56] Analogous results are obtained in
C. elegans: deletion of the BH3-only protein EGL-1 impairs starvation-
induced autophagy, whereas gain-of-function mutation increases
autophagic activity [45,56].
7. Tumour suppression
Tumour suppressor genes such as PTEN, TSC1, TSC2 and AMPK
regulate autophagy. Oncogenes have been reported to suppress
autophagy, while tumour suppressors stimulate autophagy [57–62].
Beclin 1 function is lost in certain forms of human cancer [58,63–65]. A
newly identiﬁed molecule with tumour suppressive function, UVRAG,
in turn associates with Beclin 1 to activate autophagy [58,65]. The
endophilin protein Bif-1 also associates with UVRAG and Beclin 1 to
regulate autophagosome formation. Upon induction of autophagy, Bif-
1, together with atg5 and LC3 co-localize on autophagosomes [58].
These ﬁndings provide a direct link between autophagy and cancer
[40,66,67].
Moreover, autophagy has recently been assigned tumour suppres-
sive functions following p53 activation [57]. The transcription factor
p53 arrests cell cycle upon DNA damage and activates DNA repair or
initiates apoptosis if the damage is beyond repair. Interestingly, the
damage-regulated autophagy modulator (DRAM) gene that encodes a
lysosomal protein, which induces autophagy, is a target of p53 [68].
Activation of DRAM or p53 increases the number of autophagic
vesicles in human cancer cell lines. This increase is not merely due to
impaired autophagosome turnover, since induction of autophagy by
p53 was suppressed by knockdown of the autophagy gene atg5 and
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Xenopus, Drosophila, zebraﬁsh and C. elegans [68]. An alternate
pathway for activating autophagy via p53 was recently identiﬁed in
mouse embryonic ﬁbroblasts. Speciﬁcally, p53 activates the AMP-
activated kinase, which in turn inhibits mTOR via tuberous sclerosis
complexes 1 and 2 (TSC1/TSC2) and thus induces autophagy [57,69].
Therefore, autophagy, at least in part cooperates with p53 to exert
tumour suppressive functions [69].
Intriguingly, recent studies have shown that interfering with p53
function also induces autophagy in normal and cancerous human cell
lines as well as in C. elegans [48,49]. Suppression of cep-1, the C. elegans
p53 orthologue, induces autophagy as evidenced by the induction of
expression and punctuate redistribution of ﬂuorescently tagged LGG-1
in the cytoplasm of embryos and adult pharyngeal cells [47]. This
apparent paradox can be explained if one considers early and late stage
tumour development. In this context, autophagy may exert tumour
suppressive functions early in tumour development by decreasing cell
proliferation, while later may facilitate tumour development by
providing nutrients to areas with in the tumours that cannot be
reached due to lack of vascular supply [47,65]. The totality of these
ﬁndings provide incentive for novel anti-cancer approaches that target
autophagy as a means to impair survival of tumour cells [66].
8. Neurodegeneration
Correct protein folding is essential for normal cellular function and
the survival of organisms. Abnormally folded or damaged proteins are
associated with ageing and neurodegenerative disorders. Neurons are
especially vulnerable to faulty proteome due to their post-mitotic
state. Therefore, they rely on degradative pathways for proper cellular
maintenance and function. Inability to degrade misfolded or aggre-
gated proteins leads to gradual loss of neurons, that in turn results in
neurodegenerative diseases such as Parkinson's disease, Alzheimer's
disease and polyglutamine diseases like Huntington's disease.
Autophagy ameliorates cellular stress induced by accumulation of
protein aggregates [70–72]. With its short lifespan and its transparent
body that allows for easy visualization of protein aggregates, C. elegans
provides an attractive platform for such studies. These virtues greatly
facilitate the determination of the genes and pathways involved in the
heritability, pathophysiology, and molecular mechanisms of neuro-
degenerative diseases.
Accumulation of polyglutamine (polyQ) expanded proteins in the
nucleus or the cytoplasm caused by expansion of a trinucleotide CAG
repeat, has been associated with neurodegenerative disorders such as
Huntington's disease, spinal and bulbar muscular dystrophy certain
forms of spinocerebellar ataxia [73]. These abnormal proteins form
aggregates that can only be degraded by autophagy [71,74]. For
example, in Huntington's disease, the polyglutamine repeats at the N-
terminal of huntingtin are greater than 35, while the normal number
of residue repeats is 10–30. These derivatives form intranuclear
inclusions and cytoplasmic aggregates in the striatum, the cerebral
cortex and the thalamic nuclei. To directly examine whether
autophagy serves a protective role against aggregates of expanded
polyQ proteins in C. elegans, the accumulation of such aggregates in
muscle cells or sensory neurons expressing polyQ proteins was
assayed in animals with autophagy defects [71]. These experiments
demonstrated that reduction of autophagy exacerbates the effects of
expanded polyQ protein expression resulting in elevated formation of
aggregates, consequent defects in locomotion and degeneration of
neurons expressing the abnormal proteins. These ﬁndings implicate
autophagy in the suppression of the formation of polyQ aggregates
and the protection of cells from degeneration.
Patients with Alzheimer's disease (AD) suffer from dementia,
mainly due to neurodegeneration in the neocortex. The accumulation
of amyloid plaques and neuroﬁbrillary tangles in the cerebral cortex
and certain sub-cortical areas is associatedwith the neuropathology ofthe disease. The plaques consist of aggregates of mostly insoluble
amyloid-beta protein and cellular material in the extracellular envi-
ronment of neurons. Beta-amyloid derives from abnormal proteolysis
of the amyloid precursor protein (APP), a transmembrane protein
involved in neuronal growth, cell signalling and adhesion, and
trafﬁcking [75]. The neuroﬁbrillary tangles consist of aggregates of
tau. Tau, a microtubule-associated protein that stabilizes microtubules
when phosphorylated, becomes overly phosphorylated in Alzheimer's
disease creating paired helical ﬁlaments, interfering with the neuron's
transport system [75–77]. Pathologic neurons are characterized by
accumulation of autophagic vacuoles. Human beta amyloid induces
accumulation of autophagosomes in C. elegansmuscle cells. Autopha-
gosome accumulation as assayed by formation of LGG-1::GFP puncta
in muscle cells was less in worms harbouring the daf-2(e1370) mu-
tation which has been shown to decrease insulin receptor signalling
and increase lifespan in the worm [25]. By contrast, wild type animals
showed signiﬁcantly greater accumulation of autophagosomes and
were paralyzed much sooner compared to daf-2 mutants (within
24–28 h as opposed to 36 h for the mutant animals). bec-1 knock
down diminishes autophagosome formation in muscles cells and
increases beta-amyloid toxicity. A similar effect is observed upon
inhibition of lysosomal function. In addition, decreasing insulin-
receptor signalling facilitates beta-amyloid degradation via auto-
phagy. Consistent with ﬁndings in the nematode, studies in a mouse
model of Alzheimer's disease implicate beclin 1 in the regulation of
autophagic clearance of intraneuronal beta-amyloid [78].
Motor dysfunctions, such as muscle stiffness, tremor, bradykinesia
and postural instability are common characteristics of Parkinson's
disease (PD). Dopaminergic neurons in the substantia nigra pars
compacta undergo neurodegeneration around the middle stages of
the disease. These neurons form cytoplasmic protein inclusions called
Lewy bodies, which are composed of aggregates of the polypeptide
α-synuclein, ubiquitin and 3-nitrotyrosine [79]. Lewy bodies are also a
common denominator of other diseases, such as dementia with Lewy
bodies and in some cases of dystonia [79]. Human α-synuclein
overexpression in C. elegans cells induces misfolded α-synuclein
inclusions that increase with age. Formation of these inclusions is
ameliorated by torsinA co-expression [80]. TorsinA associates with
α-synuclein in Lewy bodies [79]. Proteins of the torsin family perform
chaperone-like functions and associate with misfolded or aberrant
proteins [81]. TOR-2 is one of the three C. elegans homologues of
human torsinA. TOR-2 overexpression can suppress polyglutamine
protein aggregates [80].
To further investigate the molecular basis of Parkinson's disease
pathogenesis, nematode genes were sought that when knocked down
favour age-related aggregation of α-synuclein and thus the occur-
rence of the disease [80]. 80 C. elegans genes have been identiﬁed that
inﬂuence formation of inclusions, 49 of which have human counter-
parts [82]. Most of these genes are involved in protein quality control,
vesicle trafﬁcking between the ER and Golgi as well as other vesicular
compartments. Other genes are speciﬁcally involved in the manage-
ment or clearance of misfolded α-synuclein early in C. elegans life.
Among these genes are orthologues of known PD genes like DJ-1 and
PINK1, or the torsinA gene, T07F12.4, which is homologous to UNC-51,
involved in autophagy and axon elongation [80]. Some of the genes
identiﬁed are also related to lysosomal biogenesis, G protein signalling
and ageing [80,83]. The C. elegans homologue of the human parkin
gene has also been identiﬁed [82,84].
Amyotrophic lateral sclerosis (ALS) is another neurodegenerative
disease that affects motor neurons. Patients face problems in dexterity
or gait, have difﬁculty speaking or swallowing, and eventually become
paralyzed and lose the ability to breathe. In approximately 20% of
patients with familial ALS (1–2% of total cases), the disease is
associated with mutations in the gene encoding for the antioxidant
enzyme Cu/Zn superoxide dismutase, which removes the toxic free
radical superoxide [85]. Even though, a small percent of patients are
Fig. 3. Autophagy plays a role in cell survival and death. Basal autophagy maintains
cellular homeostasis under normal conditions, higher energy demand (e.g. in
development), and dietary restriction thus promoting survival. Impaired or excessive
autophagy leads to cell death due to defective degradation of damaged components or
misfolded proteins, which leads to their accumulation or inappropriate recycling of
essential cellular constituents.
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the protein have been linked to ALS [85]. It is proposed that accumu-
lation of mutant SOD1 upon oxidative stress leads to motor neuron
degeneration in C. elegans [86]. Interestingly, the number of
mitochondria in motor neurons is altered in patients with ALS. This
number increases signiﬁcantly in mouse motor neurons upon
administration of lithium, which retards the progression of the
disease [87,88]. Lithium has also been shown to induce autophagy
[89]. The same effect was observed with administration of rapamycin,
another autophagy inducer. These results collectively point to a
protective role for autophagy in ALS.
9. Excitotoxicity
Hyper activating, gain-of-functionmutations in speciﬁc neuronal ion
channels can trigger neuronal degeneration. In C. elegans, such
mutations in the genes mec-4 and deg-1 that encode ion channels of
the degenerin family, as well as dominant mutations in deg-3, which
encodes the alpha subunit of the nicotinic acetylcholine receptor, cause
the degeneration of neurons expressing the mutant proteins [90,91].
Increased Na+ and Ca2+ inﬂux associated with such mutant ion
channels leads to neuronal swelling and ultimately to necrotic cell death
[92]. Autophagy is required for necrotic cell death in this paradigm.
Impairment of autophagy by genetic inactivation of autophagy genes or
by pharmacological treatment suppresses necrosis. These studies in C.
elegans have shown that knock down of unc-51, bec-1 and lgg-1 among
other autophagy related genes, ameliorates neuronal degeneration
induced by abnormal ion channel activity [20,54,93]. Consistent with
these observations, reduced TOR activity, which stimulates autophagy,
promotes neuronal necrosis [54]. Furthermore, excessive autophago-
some formation is induced early during necrotic cell death. In addition,
autophagy synergizeswith lysosomal catabolicmechanisms to facilitate
cell death [4,5,93,94]. These ﬁndings demonstrate that autophagy
contributes to cellular destruction during excitotoxic cell death. Thus,
interfering with the autophagic process may protect neurons against
necrotic damage during excitotoxicity in humans.
10. Hypoxia
Hypoxia/ischemia are pathological conditions that can result in
cell demise [95]. Autophagic processes are up-regulated following
hypoxic insult in mammals and C. elegans [95,96]. The role of
autophagy following hypoxia-induced cell death, was studied by
disrupting the autophagic pathway in C. elegans [96]. Blocking
autophagy by knocking down bec-1, lgg-1 and lgg-2, unc-51 or
inhibiting BEC-1 using a phospatidylinositol-3-kinase inhibitor
increased hypoxic death compared to normal control animals.
Consistently, BEC-1 deﬁciency reduced the number of ﬂuorescently
tagged LGG-1 puncta, a marker of autophagosomes. However,
inhibiting apoptosis or suppressing necrosis prevented increasedTable 2
Phenotypes of autophagy-related gene mutations cited in this review.
Autophagy-related genes
C. elegans gene Yeast gene Mammalian gene Autophagy-related function
unc-51 ATG1 Hs ULK2/Mm Unc51.2 Required for axonal outgrowth al
bec-1 ATG6 Mm beclin 1 Arrests the development of C. ele
lgg-1 ATG8 Hs GABARAP/Mm
GABARAP-like 1
Associates with preautophagosom
pcm-1 Inhibits autophagy during dauer
daf-2 ATG3 Orthologue of the
insulin/IGF-1 receptor.
Orthologue of the insulin/IGF-1 r
skn-1 Counteracts the lifespan extensio
cep-1 p53 Cooperates with autophagy to ex
let-363 TOR HsTor/MmTor Promotes lifespan extension
The table contains autophagy genes involved with the processes described in this review.hypoxia-induced cell death in autophagy mutants. These ﬁndings
argue for a cytoprotective role of autophagy following a hypoxic insult.
11. Conclusions
Autophagy, a process for degradation of cellular material, operates
both to promote survival (e.g. following starvation) and to contribute
to cell demise. In C. elegans, autophagy has been implicated in various
processes such as cell growth and death, in ageing and longevity, as
well as in neurodegeneration (Table 2) [5,20,93]. Most studies assign a
cytoprotective role to autophagy. However, evidence that autophagy
also mediates cell death also exist (Fig. 3). The hallmark of the role of
autophagy in cell death is the signiﬁcant increase in the formation of
autophagic vacuoles. However, this observation alone is insufﬁcient to
unequivocally show that autophagy induces cell death: this increase
could reﬂect a failed survival attempt. The most pertinent evidence
has shown that autophagy fulﬁls the requirement for cell death
following inhibition or blockage of apoptosis. Nevertheless, one
cannot rule out the possibility that autophagy has indeed this dual
function [51,77,97]. Further understanding of the mechanisms thatReference
ong the antero-posterior axis [21]
gans at different stages [21,25–27,52,54]
es and autophagosomes [18,21–26,43,47,48,54,56,99]
entry [23,24]
eceptor [25,36,37]
n effects of daf-2 mutations [45]
ert tumour suppressive functions and increase lifespan [47–49]
[41,43]
1450 E.V. Megalou, N. Tavernarakis / Biochimica et Biophysica Acta 1793 (2009) 1444–1451trigger autophagic cell death will likely have signiﬁcant implications
in battling certain human diseases that appear to involve autophagy
and will contribute to the development of novel therapies. For
example, autophagy is considered as a potential target in cancer
therapy [66]. Controlled induction of autophagy has also been pro-
posed as treatment for neurodegenerative diseases characterized by
toxic accumulations of material normally degraded by autophagy, as
well as for the treatment of mood disorders [74,98]. C. elegans offers
an attractive and versatile platform for testing the validity and
optimizing the effectiveness of such approaches.
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